HCID 59309864, compound → HCID 59309922, compound
Reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([N:11]2[C:17]3[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=3[CH2:15][CH2:14][CH2:13][CH2:12]2)(=[O:10])=[O:9])=[CH:4][C:3]=1[N:22]1[C:26]2=[N:27][C:28]([CH2:32][OH:33])=[CH:29][C:30]([CH3:31])=[C:25]2[NH:24][C:23]1=[O:34]>CN(C)C=O.C(OCC)(=O)C.[O-2].[Mn+4].[O-2]>[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([S:8]([N:11]2[C:17]3[CH:18]=[CH:19][CH:20]=[CH:21][C:16]=3[CH2:15][CH2:14][CH2:13][CH2:12]2)(=[O:9])=[O:10])=[CH:4][C:3]=1[N:22]1[C:26]2=[N:27][C:28]([CH:32]=[O:33])=[CH:29][C:30]([CH3:31])=[C:25]2[NH:24][C:23]1=[O:34]Participants
5
Reactant 1
Product 1
Reagents, catalysts & solvents 3
Procedure
To a solution of 3-[2-chloro-5-(2,3,4,5-tetrahydro-1H-1-benzoazepin-1-ylsulfonyl)-phenyl]-5-hydroxymethyl-7-methyl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one (15 mg) in N,N-dimethylformamide (1 mL) was added manganese(IV) oxide (0.3 g), and the mixture was stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate, and the insoluble material was removed by filtration. The filtrate was concentrated under reduced pressure, and the residue was purified by column chromatography on silica gel (eluent: n-hexane−n-hexane/ethyl acetate=2/3) to give the title compound (12 mg).
Workup
- customthe insoluble material was removed by filtration
- concentrationThe filtrate was concentrated under reduced pressure
- customthe residue was purified by column chromatography on silica gel (eluent: n-hexane−n-hexane/ethyl acetate=2/3)
Sources & evidence
- ORD record
- ord-81d564fe610a4b75aa0e0edb3ee25500
- Source dataset
- uspto-grants-2012_07
- Patent number
- US08217069B2
Reaction notes
Loading…